Kensho is a cloud-based financial data platform for event-driven and macro analysis, targeting buy-side and sell-side financial professionals that need to quickly and efficiently backtest new trading ideas. Kensho was acquired by S&P Global in 2018 for $550M.
Region: North America
Eris Innovations
Eris Exchange is an interest rate swaps trading venue that provides the flexibility of OTC swaps within a futures contract, helping institutions manage the complexities of Dodd Frank derivatives regulations.
Codeship
Codeship is a cloud-based continuous integration and delivery (CI/CD) platform designed to automate the building, testing, and deployment of web and mobile applications.
US HealthVest
US HealthVest provides specialized, high quality psychiatric care, including substance abuse treatment, through a broad range of inpatient and outpatient programs.
Lumere
Lumere (formerly Procured Health) is an organization comprised of clinicians, researchers, pharmacists and strategic thought leaders focused on helping health systems eliminate unwarranted clinical variation and cut unnecessary costs—specifically related to device and drug selection and utilization. This company was acquired by Global Healthcare Exchange (GHX) in 2020.
Liazon
Liazon is a provider of web-based private benefits exchanges to small and medium-sized businesses. Liazon was acquired by Towers Watson in 2013.
Kyruus
Kyruus uses the science of data-driven clinical matching to ensure that patients are being matched to the right provider and enabling healthcare systems to coordinate care delivery across their provider networks. Kyruus was acquired by RevSpring in 2025.
Iora Health
Iora Health is building a different kind of health system to deliver high impact, relationship based care. Iora Health was acquired by One Medical in September 2021.
ViewRay
ViewRay (NASDAQ: VRAY) designs, manufactures and markets the MRIdian® radiation therapy system. Which uses a high-definition MR imaging system designed from the ground up to address the unique challenges and clinical workflow for advanced radiation oncology.
Ivenix
Ivenix is dedicated to eliminating infusion-related patient harm, uniquely positioned at the crossroads of healthcare IT and infusion delivery. Ivenix was acquired by Fresenius Kabi in 2022.